Millennium Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,700
| Closed | -$35.1K | – | 4105 |
|
|
2023
Q3 | $35.1K | Buy |
11,700
+2,527
| +28% | +$7.59K | ﹤0.01% | 3914 |
|
|
2023
Q2 | $283K | Buy |
9,173
+8,425
| +1,126% | +$260K | ﹤0.01% | 3556 |
|
|
2023
Q1 | $37K | Sell |
748
-2,027
| -73% | -$100K | ﹤0.01% | 4259 |
|
|
2022
Q4 | $68K | Sell |
2,775
-6,782
| -71% | -$166K | ﹤0.01% | 4391 |
|
|
2022
Q3 | $634K | Buy |
9,557
+2,224
| +30% | +$148K | ﹤0.01% | 3668 |
|
|
2022
Q2 | $304K | Sell |
7,333
-2,084
| -22% | -$86.4K | ﹤0.01% | 4218 |
|
|
2022
Q1 | $475K | Sell |
9,417
-594
| -6% | -$30K | ﹤0.01% | 4112 |
|
|
2021
Q4 | $601K | Sell |
10,011
-11
| -0.1% | -$660 | ﹤0.01% | 3872 |
|
|
2021
Q3 | $496K | Sell |
10,022
-14,742
| -60% | -$730K | ﹤0.01% | 4174 |
|
|
2021
Q2 | $1.41M | Buy |
+24,764
| New | +$1.41M | ﹤0.01% | 3437 |
|
|
2021
Q1 | – | Sell |
-3,511
| Closed | -$238K | – | 4472 |
|
|
2020
Q4 | $238K | Buy |
+3,511
| New | +$238K | ﹤0.01% | 3643 |
|
|
2020
Q3 | – | Sell |
-958
| Closed | -$161K | – | 3603 |
|
|
2020
Q2 | $161K | Sell |
958
-12,245
| -93% | -$2.06M | ﹤0.01% | 3165 |
|
|
2020
Q1 | $919K | Buy |
+13,203
| New | +$919K | ﹤0.01% | 2026 |
|